Comparable stake leader
CorMedix Inc.
SEC ownership of TALPHERA, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001427925.
Disclosed value leader
Rosalind Advisors, Inc.
Comparable rows
48/50
Latest evidence
02 Apr 2026
- Public ticker
- TLPH on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
CorMedix Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
48 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
CorMedix Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
02 Apr 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001427925
- Issuer location
- San Mateo, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of TALPHERA, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CorMedix Inc.
Disclosed value leader
Rosalind Advisors, Inc.
Comparable rows
48/50
Latest evidence
02 Apr 2026
13D/G
3/4/5
13F
Lead comparable stake: 20%
2 rows are not safely comparable across share classes.
13D/G row: CorMedix Inc.
Showing 1-8 of 50 holder rows.
Quick read
CorMedix Inc. leads the comparable SEC ownership view at 20%.
48 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CorMedix Inc.'s linked filing trail.
Comparable ownership
Top 5
CorMedix Inc.
20%
Nantahala Capital Management, LLC
12%
Rosalind Advisors, Inc.
9.9%
Orin Hirschman
9.8%
Rock Springs Capital Management LP
7.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CorMedix Inc. |
13D/G
3/4/5
10%+ Owner
|
20%
|
$3,909,091
9,090,909 shares
|
$0 | 07 Sep 2025 |
| Nantahala Capital Management, LLC |
3/4/5
13D/G
13F
Other*, 10%+ Owner · Company
|
12%
from 13D/G
|
$6,733,702
18,822,267 shares
|
— | 13 Mar 2026 |
| Rosalind Advisors, Inc. |
13D/G
13F
Company
|
9.9%
|
$13,545,483
13,150,954 shares
|
-$830,679 | 31 Dec 2025 |
| Orin Hirschman |
13D/G
|
9.8%
|
$5,127,652
4,661,502 shares
|
+$227,653 | 31 Dec 2025 |
| Rock Springs Capital Management LP |
13F
13D/G
Company
|
7.9%
from 13D/G
|
$2,680,763
3,589,186 shares
|
— | 31 Mar 2026 |
| Laurence W. Lytton |
13D/G
LYTTON LAURENCE W
|
2.5%
|
$1,009,620
1,246,444 shares
|
-$1,202,262 | 31 Mar 2026 |
| AIGH Capital Management LLC |
13F
Company
|
9.3%
|
$3,481,676
4,661,502 shares
|
— | 31 Mar 2026 |
| Bleichroeder LP |
13F
Company
|
2.6%
|
$976,786
1,307,787 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$304,001.
Buys
$304,001
Insiders: 4
Sells
$0
Insiders: 0
Net
+$304,001
Shares: +433,674
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 433,674
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 433,674 | 0 | $304,001 | $0 | +$304,001 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-17 of 17 reporting-owner rows connected to TALPHERA, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
17
Largest Forms 3/4/5 holder
Nantahala Capital Management, LLC
Net 12M change
+$304,003
Latest report
20 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | Other*, 10%+ Owner | $6,733,702 | Mixed | 13 Mar 2026 | ||
| CorMedix Inc. | 10%+ Owner | $3,909,090 | Mixed | 07 Sep 2025 | ||
| Vincent J. Angotti | CHIEF EXECUTIVE OFFICER, Director | $901,474 | +$210,587 | +30% | Mixed | 02 Apr 2026 |
| Mark G. Edwards | Director | $189,877 | Mixed | 17 Jun 2021 | ||
| Raffi Asadorian | Chief Financial Officer | $172,029 | +$36,554 | +27% | Mixed | 02 Apr 2026 |
| Shakil Aslam | Chief Medical Officer | $82,004 | +$28,431 | +53% | Mixed | 20 May 2026 |
| Badri N. Dasu | Chief Engineering Officer | $81,441 | +$28,431 | +54% | Mixed | 02 Apr 2026 |
| Pamela P. Palmer | Chief Medical Officer | $65,064 | Mixed | 03 Mar 2024 | ||
| Adrian Adams | Director | $15,703 | Mixed | 23 Oct 2025 | ||
| Marina Bozilenko | Director | $8,068 | Mixed | 23 Oct 2025 | ||
| Mark A. Wan | Director | $7,900 | Mixed | 23 Oct 2025 | ||
| Stephen J. Hoffman | Director | $7,900 | Mixed | 23 Oct 2025 | ||
| Jill Marie Broadfoot | Director | $7,622 | Mixed | 23 Oct 2025 | ||
| Abhinav Jain | Director | $6,520 | Mixed | 23 Oct 2025 | ||
| Joseph Todisco | Director | $5,821 | Mixed | 15 Oct 2025 | ||
| Howard B. Rosen | Director | $3,847 | Mixed | 10 Oct 2023 | ||
| Richard Afable | Director | $1,794 | Mixed | 10 Oct 2023 |
Recent insider transactions for TALPHERA, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Shakil Aslam | TLPH | Common Stock | Tax liability | -5.57% | -4,518 | 76,542 | 20 May 2026 | Direct | ||
| Vincent J. Angotti | TLPH | Common Stock | Tax liability | -1.24% | -9,938 | 790,767 | 02 Apr 2026 | Direct | ||
| Raffi Asadorian | TLPH | Common Stock | Tax liability | -2.77% | -2,444 | 85,879 | 02 Apr 2026 | Direct | ||
| Shakil Aslam | TLPH | Common Stock | Tax liability | -2.55% | -2,118 | 81,060 | 02 Apr 2026 | Direct | ||
| Badri N. Dasu | TLPH | Common Stock | Tax liability | -3.31% | -2,444 | 71,440 | 02 Apr 2026 | Direct | ||
| Vincent J. Angotti | TLPH | Common Stock | Purchase | 36.3% | $125,000 | $0.5860 | 213,310 | 800,705 | 13 Mar 2026 | Direct |
| Nantahala Capital Management, LLC | TLPH | Pre-Funded Warrants | Award | 29.3% | 4,266,211 | 18,822,267 | 13 Mar 2026 | See Footnote | ||
| Vincent J. Angotti | TLPH | Common Stock | Tax liability | -1.63% | -9,559 | 577,395 | 14 Feb 2026 | Direct | ||
| Badri N. Dasu | TLPH | Common Stock | Tax liability | -3.08% | -2,346 | 73,884 | 14 Feb 2026 | Direct | ||
| Raffi Asadorian | TLPH | Common Stock | Tax liability | -3.21% | -2,933 | 88,323 | 14 Feb 2026 | Direct | ||
| Vincent J. Angotti | TLPH | Common Stock | Purchase | 21.9% | $85,587 | $0.8123 | 105,364 | 586,954 | 12 Feb 2026 | Direct |
| Vincent J. Angotti | TLPH | Stock Option (Right to Buy) | Award | 594,000 | 594,000 | 12 Feb 2026 | Direct | |||
| Shakil Aslam | TLPH | Common Stock | Purchase | 72.6% | $28,430 | $0.8123 | 35,000 | 83,178 | 12 Feb 2026 | Direct |
| Shakil Aslam | TLPH | Stock Option (Right to Buy) | Award | 205,000 | 205,000 | 12 Feb 2026 | Direct | |||
| Badri N. Dasu | TLPH | Common Stock | Purchase | 84.9% | $28,430 | $0.8123 | 35,000 | 76,230 | 12 Feb 2026 | Direct |
| Badri N. Dasu | TLPH | Stock Option (Right to Buy) | Award | 200,000 | 200,000 | 12 Feb 2026 | Direct | |||
| Raffi Asadorian | TLPH | Commom Stock | Purchase | 97.3% | $36,554 | $0.8123 | 45,000 | 91,256 | 12 Feb 2026 | Direct |
| Raffi Asadorian | TLPH | Stock Option (Right to Buy) | Award | 260,000 | 260,000 | 12 Feb 2026 | Direct | |||
| Vincent J. Angotti | TLPH | Common Stock | Tax liability | -0.66% | -3,179 | 481,590 | 10 Feb 2026 | Direct | ||
| Badri N. Dasu | TLPH | Common Stock | Tax liability | -1.86% | -781 | 41,230 | 10 Feb 2026 | Direct | ||
| Raffi Asadorian | TLPH | Common Stock | Tax liability | -2.03% | -958 | 46,256 | 10 Feb 2026 | Direct | ||
| Stephen J. Hoffman | TLPH | Common Stock | Award | 92.9% | 4,267 | 8,859 | 23 Oct 2025 | Direct | ||
| Stephen J. Hoffman | TLPH | Stock Option (Right to Buy) | Award | 25,600 | 25,600 | 23 Oct 2025 | Direct | |||
| Mark A. Wan | TLPH | Common Stock | Award | 92.9% | 4,267 | 8,859 | 23 Oct 2025 | Direct | ||
| Mark A. Wan | TLPH | Stock Option (Right to Buy) | Award | 25,600 | 25,600 | 23 Oct 2025 | Direct | |||
| Marina Bozilenko | TLPH | Common Stock | Award | 89.3% | 4,267 | 9,047 | 23 Oct 2025 | Direct | ||
| Marina Bozilenko | TLPH | Stock Option (Right to Buy) | Award | 25,600 | 25,600 | 23 Oct 2025 | Direct | |||
| Jill Marie Broadfoot | TLPH | Common Stock | Award | 99.7% | 4,267 | 8,547 | 23 Oct 2025 | Direct | ||
| Jill Marie Broadfoot | TLPH | Stock Option (Right to Buy) | Award | 25,600 | 25,600 | 23 Oct 2025 | Direct | |||
| Adrian Adams | TLPH | Common Stock | Award | 32% | 4,267 | 17,609 | 23 Oct 2025 | Direct | ||
| Adrian Adams | TLPH | Stock Option (Right to Buy) | Award | 25,600 | 25,600 | 23 Oct 2025 | Direct | |||
| Abhinav Jain | TLPH | Common Stock | Award | 140.1% | 4,267 | 7,312 | 23 Oct 2025 | Direct | ||
| Abhinav Jain | TLPH | Stock Option (Right to Buy) | Award | 25,600 | 25,600 | 23 Oct 2025 | Direct | |||
| Joseph Todisco | TLPH | Common Stock | Award | 6,397 | 6,397 | 15 Oct 2025 | Direct | |||
| Joseph Todisco | TLPH | Director Stock Option (right to buy) | Award | 38,381 | 38,381 | 15 Oct 2025 | Direct |
* marks a reported price that did not pass the local price check.